Nucleophosmin 1 Mutations in Acute Myeloid Leukemia

被引:45
|
作者
Zarka, Jabra [1 ]
Short, Nicholas J. [1 ]
Kanagal-Shamanna, Rashmi [2 ]
Issa, Ghayas C. [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA
关键词
AML; nucleophosmin (NPM1); gene expression; targeted therapies; TUMOR-SUPPRESSOR PROTEIN; ACUTE MYELOGENOUS LEUKEMIA; MINIMAL RESIDUAL DISEASE; GENE-EXPRESSION PROFILE; NPM1; MUTATIONS; CLONAL HEMATOPOIESIS; MUTANT NUCLEOPHOSMIN; RIBOSOME BIOGENESIS; RETINOIC ACID; CYTOPLASMIC NUCLEOPHOSMIN;
D O I
10.3390/genes11060649
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Nucleophosmin (NPM1) is a ubiquitously expressed nucleolar protein involved in ribosome biogenesis, the maintenance of genomic integrity and the regulation of the ARF-p53 tumor-suppressor pathway among multiple other functions. Mutations in the corresponding gene cause a cytoplasmic dislocation of the NPM1 protein. These mutations are unique to acute myeloid leukemia (AML), a disease characterized by clonal expansion, impaired differentiation and the proliferation of myeloid cells in the bone marrow. Despite our improved understanding ofNPM1mutations and their consequences, the underlying leukemia pathogenesis is still unclear. Recent studies that focused on dysregulated gene expression in AML with mutatedNPM1have shed more light into these mechanisms. In this article, we review the current evidence on normal functions of NPM1 and aberrant functioning in AML, and highlight investigational strategies targeting these mutations.
引用
收藏
页码:1 / 16
页数:16
相关论文
共 50 条
  • [41] Nucleophosmin (NPM1) mutations in acute myeloid leukemia:: An ongoing (cytoplasmic) tale of dueling mutations and duality of molecular genetic testing methodologies
    Wertheim, Gerald
    Bagg, Adam
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2008, 10 (03): : 198 - 202
  • [42] Detection of nucleophosmin gene mutations in plasma from patients with acute myeloid leukemia: Clinical significance and implications
    Ma, Wanlong
    Zhang, Xi
    Jilani, Iman
    Ravandi, Farhad
    Estey, Elihu
    Kantarjian, Hagop
    Giles, Francis
    Sheikholeslami, Mohammad
    Keating, Michael
    Albitar, Maher
    BLOOD, 2007, 110 (11) : 840A - 840A
  • [43] Nucleophosmin mutations confer an independent favorable prognostic impact in 869 pediatric patients with acute myeloid leukemia
    Xu, Lu-Hong
    Fang, Jian-Pei
    Liu, Yao-Chung
    Jones, Adrianna I.
    Chai, Li
    BLOOD CANCER JOURNAL, 2020, 10 (01)
  • [44] Nucleophosmin mutations confer an independent favorable prognostic impact in 869 pediatric patients with acute myeloid leukemia
    Lu-Hong Xu
    Jian-Pei Fang
    Yao-Chung Liu
    Adrianna I. Jones
    Li Chai
    Blood Cancer Journal, 10
  • [45] Nucleophosmin gene mutations identify a favorable risk group in childhood acute myeloid leukemia with a normal karyotype
    Hollink, Iris H.
    Zwaan, Christian M.
    Van den Heuvel-Eibrink, Marry M.
    Zimmerman, Martin
    Aretitsen-Peters, Susan
    Pieters, Rob
    Cloos, Jacqueline
    Kaspers, Gertjan J.
    De Graaf, Siebold S.
    Creutzig, Ursula
    Reinhardt, Dirk
    Thiede, Christian
    BLOOD, 2007, 110 (11) : 115A - 115A
  • [46] Detection of nucleophosmin gene mutations in plasma from patients with acute myeloid leukemia: Clinical significance and implications
    Ma, Wanlong
    Kantarjian, Hagop
    Zhang, Xi
    Jilani, Iman
    Sheikholeslami, Mohammad R.
    Donahue, Amber C.
    Ravandi, Farhad
    Estey, Elihu
    O'Brien, Susan
    Keating, Michael
    Giles, Francis J.
    Albitar, Maher
    CANCER BIOMARKERS, 2009, 5 (01) : 51 - 58
  • [47] Role of Nucleophosmin Gene Mutation in Leukemogenesis of Acute Myeloid Leukemia
    Khaled, Safaa A. A.
    Burthem, John
    Elnoor, El-Badry E. Abo
    ElToni, Lobna F.
    Ahmed, Hanan M.
    Ahmed, Sohier M.
    JOURNAL OF HEMATOLOGY, 2018, 7 (01) : 7 - 13
  • [48] Nucleophosmin Immunohistochemistry in Residual Disease Detection of Acute Myeloid Leukemia
    Dai, Qian
    Ren, Yongsheng
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2012, 138 : A160 - A160
  • [49] Nucleophosmin mutation in de-novo acute myeloid leukemia
    Rastogi, Pulkit
    Naseem, Shano
    Varma, Neelam
    Varma, Subhash
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 (01) : 77 - 85
  • [50] Nucleophosmin mutation as a favorable prognostic marker in acute myeloid leukemia
    Jim Casey
    Nature Clinical Practice Oncology, 2006, 3 (2): : 68 - 69